Annovis Bio, Inc. (ANVS)
$1.75-3.85%Close
BUYRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV8.0%–475.3%
- Market cap
- $34M
- Avg volume
- 948.5K
- Beta
- 1.24
- P/E (TTM)
- -0.97
- IV-%ile
- 76
- IV ATM
- 307.2%
- Short % float
- 31.81%
- Days to cover
- 9.4
- SI change
- -4.7%
- 1W
- +0.57%
- 1M
- +5.42%
- 3M
- -21.52%
- YTD
- -52.05%
- vs SPY 1W
- +1.77%
- vs SPY 1M
- +2.10%
- vs SPY 3M
- -23.92%
- vs SPY YTD
- -63.81%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SPRCBUYSciSparc Ltd.RECOVERYQ -24$6.66-0.60%
- CURXBUYCuranex Pharmaceuticals Inc Common StockRECOVERYQ -46$4.63-1.70%
- NNOXSELLNano-X Imaging Ltd.CRISISQ -9$0.86+0.00%
- CUESELLCue Biopharma, Inc.CRISISQ -1$23.18-3.34%
- TNONBUYTenon Medical, Inc.CRISISQ -26$6.31-7.61%
- KODSELLKodiak Sciences Inc.CRISISQ 37$37.22-2.90%
- RGCSELLRegencell Bioscience Holdings LimitedCRISISQ 37$5.29-0.19%
- TRAWSELLTraws Pharma, Inc.RECOVERYQ -22$0.56+5.66%
- BCRXBUYBioCryst Pharmaceuticals, Inc.RECOVERYQ 6$9.68+1.36%
- MBIOSELLMustang Bio, Inc.CRISISQ -18$0.55-5.17%
- OWLTBUYOwlet, Inc.CRISISQ -21$5.08-2.31%
- DERMBUYJourney Medical CorporationRECOVERYQ 7$7.91+2.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 7
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-224.7%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.97
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-15.43
P/FCF-
EV/EBITDA-1.14
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO2.95
ND/EBITDA-
BETA1.24
